List of Omrix Biopharmaceuticals patents

Patents where

Current Assignee

Name

Omrix Biopharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11426483 Wound dressing and a method for producing the same	Patent 11426483 was granted and assigned to Omrix Biopharmaceuticals on August, 2022 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	11426483	August 30, 2022
‌ US Patent 7125569 Removal of plasmin(ogen) from protein solutions	Patent 7125569 was granted and assigned to Omrix Biopharmaceuticals on October, 2006 by the United States Patent and Trademark Office.		Omrix Biopharmaceuticals	United States Patent and Trademark Office	7125569	October 24, 2006
‌ US Patent 10039865 Implantable device comprising a substrate pre-coated with stabilized fibrin	Patent 10039865 was granted and assigned to Omrix Biopharmaceuticals on August, 2018 by the United States Patent and Trademark Office.		Omrix Biopharmaceuticals	United States Patent and Trademark Office	10039865	August 7, 2018
‌ US Patent 11484623 Dry pad comprising thrombin and pectin	Patent 11484623 was granted and assigned to Omrix Biopharmaceuticals on November, 2022 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	11484623	November 1, 2022
‌ US Patent 9867852 Viral inactivated biological mixture	Patent 9867852 was granted and assigned to Omrix Biopharmaceuticals on January, 2018 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	9867852	January 16, 2018
‌ US Patent 8962033 Method for improved fibrin sealing	Patent 8962033 was granted and assigned to Omrix Biopharmaceuticals on February, 2015 by the United States Patent and Trademark Office.		Omrix Biopharmaceuticals	United States Patent and Trademark Office	8962033	February 24, 2015
‌ US Patent 9023994 Immunoglobulin reduced in thrombogenic agents and preparation thereof	Patent 9023994 was granted and assigned to Omrix Biopharmaceuticals on May, 2015 by the United States Patent and Trademark Office.		Omrix Biopharmaceuticals	United States Patent and Trademark Office	9023994	May 5, 2015
‌ US Patent 9943546 Viral inactivated platelet extract, use and preparation thereof	Patent 9943546 was granted and assigned to Omrix Biopharmaceuticals on April, 2018 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	9943546	April 17, 2018
‌ US Patent 10357589 One component fibrin glue comprising a polymerization inhibitor	Patent 10357589 was granted and assigned to Omrix Biopharmaceuticals on July, 2019 by the United States Patent and Trademark Office.		Omrix Biopharmaceuticals	United States Patent and Trademark Office	10357589	July 23, 2019
‌ US Patent 10466258 Device and process for sample preparation	Patent 10466258 was granted and assigned to Omrix Biopharmaceuticals on November, 2019 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	10466258	November 5, 2019
‌ US Patent 9326998 Compositions suitable for treatment of spinal disease, disorder or condition	Patent 9326998 was granted and assigned to Omrix Biopharmaceuticals on May, 2016 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	9326998	May 3, 2016
‌ US Patent 9302026 Method for improved fibrin sealing	Patent 9302026 was granted and assigned to Omrix Biopharmaceuticals on April, 2016 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	9302026	April 5, 2016
‌ US Patent 9365635 Intravenous immunoglobulin composition	Patent 9365635 was granted and assigned to Omrix Biopharmaceuticals on June, 2016 by the United States Patent and Trademark Office.		Omrix Biopharmaceuticals	United States Patent and Trademark Office	9365635	June 14, 2016
‌ US Patent 9657087 Subcutaneous administration of anti-hepatitis B antibodies	Patent 9657087 was granted and assigned to Omrix Biopharmaceuticals on May, 2017 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	9657087	May 23, 2017
‌ US Patent 8968724 Compositions suitable for treatment of spinal disease, disorder or condition	Patent 8968724 was granted and assigned to Omrix Biopharmaceuticals on March, 2015 by the United States Patent and Trademark Office.		Omrix Biopharmaceuticals	United States Patent and Trademark Office	8968724	March 3, 2015
‌ US Patent 10538754 Method for preparation of thrombin	Patent 10538754 was granted and assigned to Omrix Biopharmaceuticals on January, 2020 by the United States Patent and Trademark Office.		Omrix Biopharmaceuticals	United States Patent and Trademark Office	10538754	January 21, 2020
‌ US Patent 8354249 Intravenous immunoglobulin composition	Patent 8354249 was granted and assigned to Omrix Biopharmaceuticals on January, 2013 by the United States Patent and Trademark Office.		Omrix Biopharmaceuticals	United States Patent and Trademark Office	8354249	January 15, 2013
‌ US Patent 10159719 Kit with stabilized thrombin	Patent 10159719 was granted and assigned to Omrix Biopharmaceuticals on December, 2018 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	10159719	December 25, 2018
‌ US Patent 11008560 Method for purifying and quantifying thrombin and its degradation polypeptides	Patent 11008560 was granted and assigned to Omrix Biopharmaceuticals on May, 2021 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	11008560	May 18, 2021
‌ US Patent 11225652 Thrombin solution and methods of use thereof	Patent 11225652 was granted and assigned to Omrix Biopharmaceuticals on January, 2022 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	11225652	January 18, 2022
‌ US Patent 9278181 Devices for injecting a substance and methods therefor	Patent 9278181 was granted and assigned to Omrix Biopharmaceuticals on March, 2016 by the United States Patent and Trademark Office.		Omrix Biopharmaceuticals	United States Patent and Trademark Office	9278181	March 8, 2016
‌ US Patent 9057737 Immunoassay for thrombin detection	Patent 9057737 was granted and assigned to Omrix Biopharmaceuticals on June, 2015 by the United States Patent and Trademark Office.		Omrix Biopharmaceuticals	United States Patent and Trademark Office	9057737	June 16, 2015
‌ US Patent 10130346 Device and method for the application of a curable fluid composition to a bodily organ	Patent 10130346 was granted and assigned to Omrix Biopharmaceuticals on November, 2018 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	10130346	November 20, 2018
‌ US Patent 8450067 Method for obtaining anti-idiotype antibodies	Patent 8450067 was granted and assigned to Omrix Biopharmaceuticals on May, 2013 by the United States Patent and Trademark Office.		Omrix Biopharmaceuticals	United States Patent and Trademark Office	8450067	May 28, 2013
‌ US Patent 10849605 Device and method for the application of a curable fluid composition to a portion of a bodily organ	Patent 10849605 was granted and assigned to Omrix Biopharmaceuticals on December, 2020 by the United States Patent and Trademark Office.	Omrix Biopharmaceuticals	Omrix Biopharmaceuticals	United States Patent and Trademark Office	10849605	December 1, 2020

Results per page:

55 results

0 selected

55 results

0 selected